Literature DB >> 6692235

Strategies for the drug treatment of depression.

A J Cooper, R V Magnus.   

Abstract

Antidepressants are a useful addition to a physician's therapeutic armamentarium, but because they are used to treat disorders of diverse and largely unknown cause, there is a much greater element of chance associated with their use than with the use of many other types of drugs (e.g., antibiotics and analgesics). Nevertheless, empirically derived treatment schemes, applied systematically, increase the odds of a favourable response and are preferred to haphazard prescribing. To date, no one antidepressant has been shown to be more effective than any other, although the newer agents are alleged to be faster acting, more specific and less toxic than the established drugs. However, generally, such claims have not been proven clinically. Unless there are overwhelming contraindications (e.g., intolerable side effects, an idiosyncratic response or coexisting cardiac disease) the established agents, with their proven efficacy, are preferred initially.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692235      PMCID: PMC1876118     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  45 in total

1.  DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY.

Authors:  M GREENBLATT; G H GROSSER; H WECHSLER
Journal:  Am J Psychiatry       Date:  1964-04       Impact factor: 18.112

Review 2.  The clinical pharmacology of imipramine. Implications for therapeutics.

Authors:  A H Glassman; J M Perel
Journal:  Arch Gen Psychiatry       Date:  1973-05

3.  Phenelzine in phobic anxiety: a controlled trial.

Authors:  P Tyrer; J Candy; D Kelly
Journal:  Psychol Med       Date:  1973-02       Impact factor: 7.723

4.  Plasma concentration of amitriptyline and clinical response.

Authors:  R A Braithwaite; R Goulding; G Theano; J Bailey; A Coppen
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

5.  Plasma-nortriptyline levels in endogenous depression.

Authors:  P Kragh-Sørensen; M Asberg; C Eggert-Hansen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

6.  Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.

Authors:  A Raskin; J G Schulterbrandt; N Reatig; J J McKeon
Journal:  Arch Gen Psychiatry       Date:  1970-08

7.  Potentiation of a monoamine oxidase inhibitor by tryptophan.

Authors:  A H Glassman; S R Platman
Journal:  J Psychiatr Res       Date:  1969-12       Impact factor: 4.791

8.  Behaviour therapy versus drug therapy in the treatment of phobic neurosis.

Authors:  L Solyom; G F Heseltine; D J McClure; C Solyom; B Ledwidge; G Steinberg
Journal:  Can Psychiatr Assoc J       Date:  1973-02

9.  Modification of insulin and sulfonylurea hypoglycemia by monoamine-oxidase inhibitor drugs.

Authors:  A J Cooper; G Ashcroft
Journal:  Diabetes       Date:  1967-04       Impact factor: 9.461

10.  Relationship between plasma level and therapeutic effect of nortriptyline.

Authors:  M Asberg; B Crönholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1971-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.